4.7 Review

Lipids in Innate Antiviral Defense

期刊

CELL HOST & MICROBE
卷 14, 期 4, 页码 379-385

出版社

CELL PRESS
DOI: 10.1016/j.chom.2013.09.010

关键词

-

资金

  1. NIAID [AI080703, AI102236]
  2. American Cancer Society [118676-RSG-10-059-01-MPC]
  3. NIDDK [DK095031]

向作者/读者索取更多资源

It is becoming apparent that infections by a major class of viruses, those with envelopes, can be inhibited during their entry at the step of fusion with cellular membranes. In this review, we discuss multiple innate immune mechanisms that have evolved to modify the lipid composition of cellular and viral membranes to inhibit virion fusion of enveloped viruses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids

Jan Wysocki, Minghao Ye, Luise Hassler, Ashwani Kumar Gupta, Yuguo Wang, Vlad Nicoleascu, Glenn Randall, Jason A. Wertheim, Daniel Batlle

Summary: A novel ACE2 variant has been developed that can neutralize SARS-CoV-2 infectivity in human kidney organoids, with prolonged duration of action and potential for improved efficacy.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Review Virology

Three-Dimensional Cell Culture Systems for Studying Hepatitis C Virus

Chui-Wa So, Glenn Randall

Summary: Hepatocytes, the main target of HCV, require extensive trafficking in polarized cells for infection. Researchers are utilizing three-dimensional cell culture models resembling in vivo hepatocytes to study HCV infection.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors

Jerzy Osipiuk, Saara-Anne Azizi, Steve Dvorkin, Michael Endres, Robert Jedrzejczak, Krysten A. Jones, Soowon Kang, Rahul S. Kathayat, Youngchang Kim, Vladislav G. Lisnyak, Samantha L. Maki, Vlad Nicolaescu, Cooper A. Taylor, Christine Tesar, Yu-An Zhang, Zhiyao Zhou, Glenn Randall, Karolina Michalska, Scott A. Snyder, Bryan C. Dickinson, Andrzej Joachimiak

Summary: The study focused on papain-like protease (PLpro) as a potential target for antivirals against SARS-CoV-2, identifying inhibitors and their interactions with the enzyme. The findings demonstrate the potential for developing high-affinity inhibitors through structure-based drug design efforts targeting PLpro.

NATURE COMMUNICATIONS (2021)

Article Biology

Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2

Youngchang Kim, Jacek Wower, Natalia Maltseva, Changsoo Chang, Robert Jedrzejczak, Mateusz Wilamowski, Soowon Kang, Vlad Nicolaescu, Glenn Randall, Karolina Michalska, Andrzej Joachimiak

Summary: SARS-CoV-2 Nsp15 is a uridine-specific endoribonuclease that interferes with the innate immune response and is a potential target for therapeutic intervention. Studies have shown that Tipiracil inhibits the activity of Nsp15 by interacting with the uridine binding pocket. This discovery provides new insights for the development of drugs based on uracil scaffold.

COMMUNICATIONS BIOLOGY (2021)

Article Multidisciplinary Sciences

Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2

Lamiaa El-Shennawy, Andrew D. Hoffmann, Nurmaa Khund Dashzeveg, Kathleen M. McAndrews, Paul J. Mehl, Daphne Cornish, Zihao Yu, Valerie L. Tokars, Vlad Nicolaescu, Anastasia Tomatsidou, Chengsheng Mao, Christopher J. Felicelli, Chia-Feng Tsai, Carolina Ostiguin, Yuzhi Jia, Lin Li, Kevin Furlong, Jan Wysocki, Xin Luo, Carolina F. Ruivo, Daniel Batlle, Thomas J. Hope, Yang Shen, Young Kwang Chae, Hui Zhang, Valerie S. LeBleu, Tujin Shi, Suchitra Swaminathan, Yuan Luo, Dominique Missiakas, Glenn C. Randall, Alexis R. Demonbreun, Michael G. Ison, Raghu Kalluri, Deyu Fang, Huiping Liu

Summary: El-Shennawy et al. found that circulating extracellular vesicles (evACE2) are associated with COVID-19 severity and have a higher efficacy in inhibiting the infection of SARS-CoV-2 variants compared to soluble ACE2. This study is important for the development of therapeutic approaches against current and future coronavirus infections.

NATURE COMMUNICATIONS (2022)

Article Chemistry, Multidisciplinary

A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2

Xiaolei Cai, Min Chen, Aleksander Prominski, Yiliang Lin, Nicholas Ankenbruck, Jillian Rosenberg, Mindy Nguyen, Jiuyun Shi, Anastasia Tomatsidou, Glenn Randall, Dominique Missiakas, John Fung, Eugene B. Chang, Pablo Penaloza-MacMaster, Bozhi Tian, Jun Huang

Summary: The study introduces a multifunctional nanoparticle that can capture and inactivate SARS-CoV-2 virus, efficiently blocking viral infection to host cells through surface neutralizing antibodies in vitro. Additionally, the nanoparticle has photothermal function to generate heat for virus inactivation. It significantly outperforms neutralizing antibodies in treating authentic SARS-CoV-2 infection in vivo and provides a flexible platform for potential broad protection against SARS-CoV-2 and its variants.

ADVANCED SCIENCE (2022)

Article Multidisciplinary Sciences

Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses

Long Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, Thomas J. Best, Haley Gula, Divyasha Saxena, Jon D. Gabbard, Shao-Nong Chen, Takashi Ohtsuki, John Brent Friesen, Nir Drayman, Adil Mohamed, Christopher Dann, Diane Silva, Lydia Robinson-Mailman, Andrea Valdespino, Leticia Stock, Eva Suarez, Krysten A. Jones, Saara-Anne Azizi, Jennifer K. Demarco, William E. Severson, Charles D. Anderson, James Michael Millis, Bryan C. Dickinson, Savas Tay, Scott A. Oakes, Guido F. Pauli, Kenneth E. Palmer, David O. Meltzer, Glenn Randall, Marsha Rich Rosner

Summary: This study found that cannabidiol (CBD) can inhibit the infection of SARS-CoV-2 in cells and mice, potentially making it a preventative agent for early-stage SARS-CoV-2 infection. The study also discovered that CBD inhibits SARS-CoV-2 replication partially by regulating the host cell's endoplasmic reticulum stress response and interferon signaling pathways. However, the current use of non-medical formulations for prevention or treatment is not recommended.

SCIENCE ADVANCES (2022)

Article Biochemistry & Molecular Biology

The cargo adapter protein CLINT1 is phosphorylated by the Numb-associated kinase BIKE and mediates dengue virus infection

Stanford Schor, Szuyuan Pu, Vlad Nicolaescu, Siavash Azari, Mardo Koivomagi, Marwah Karim, Patricia Cassonnet, Sirle Saul, Gregory Neveu, Andrew Yueh, Caroline Demeret, Jan M. Skotheim, Yves Jacob, Glenn Randall, Shirit Einav

Summary: The study identifies the substrates and pathways regulated by the understudied Numb-associated kinase enzyme BIKE, reveals the mechanism of CLINT1 regulation in DENV infection, and suggests potential roles of BIKE in host immune and stress responses as well as the ubiquitin proteasome system. These findings have implications for cell biology, virology, and host-targeted antiviral design.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Urology & Nephrology

A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection

Luise Hassler, Jan Wysocki, Ian Gelarden, Isha Sharma, Anastasia Tomatsidou, Minghao Ye, Haley Gula, Vlad Nicoleascu, Glenn Randall, Sergii Pshenychnyi, Nigar Khurram, Yashpal Kanwar, Dominique Missiakas, Jack Henkin, Anjana Yeldandi, Daniel Batlle

Summary: This study demonstrates the preclinical efficacy of a novel soluble ACE2 protein in a lethal mouse model of SARS-CoV-2 infection, reducing lung and kidney injury.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Multidisciplinary Sciences

Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model

Qizhou Lian, Kui Zhang, Zhao Zhang, Fuyu Duan, Liyan Guo, Weiren Luo, Bobo Wing-Yee Mok, Abhimanyu Thakur, Xiaoshan Ke, Pedram Motallebnejad, Vlad Nicolaescu, Jonathan Chen, Chui Yan Ma, Xiaoya Zhou, Shuo Han, Teng Han, Wei Zhang, Adrian Y. Tan, Tuo Zhang, Xing Wang, Dong Xu, Jenny Xiang, Aimin Xu, Can Liao, Fang-Ping Huang, Ya-Wen Chen, Jie Na, Glenn Randall, Hung-fat Tse, Zhiwei Chen, Yin Chen, Huanhuan Joyce Chen

Summary: This study uses a lung and macrophage co-culture system derived from human pluripotent stem cells to investigate the phenotype and gene expression changes in host lung cells and macrophages after SARS-CoV-2 infection. The researchers found differential immune response patterns in distinct macrophage phenotypes, which could contribute to the severity of COVID-19 disease.

NATURE COMMUNICATIONS (2022)

Article Biotechnology & Applied Microbiology

A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets

Yadi Zhou, Yuan Liu, Shagun Gupta, Mauricio Paramo, Yuan Hou, Chengsheng Mao, Yuan Luo, Julius Judd, Shayne Wierbowski, Marta Bertolotti, Mriganka Nerkar, Lara Jehi, Nir Drayman, Vlad Nicolaescu, Haley Gula, Savas Tay, Glenn Randall, Peihui Wang, John T. Lis, Cedric Feschotte, Serpil C. Erzurum, Feixiong Cheng, Haiyuan Yu

Summary: Studying the interaction between viral and host proteins can help discover therapies for viral infections. In this study, a comprehensive network of interactions between SARS-CoV-2 and human proteins was generated using high-throughput techniques, validating known host factors and identifying new ones. The network showed the highest overlap with differentially expressed genes in COVID-19 patients and revealed an interaction between a viral protein and a human transcription factor. Additionally, network-based screening of FDA-approved or investigational drugs identified several candidates with significant proximity to SARS-CoV-2 host factors, including a drug called carvedilol which showed clinical benefits and antiviral properties.

NATURE BIOTECHNOLOGY (2022)

Article Microbiology

SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells

Long C. Nguyen, David M. Renner, Diane Silva, Dongbo Yang, Nicholas Parenti, Kaeri M. Medina, Vlad Nicolaescu, Haley Gula, Nir Drayman, Andrea Valdespino, Adil Mohamed, Christopher Dann, Kristin Wannemo, Lydia Robinson-Mailman, Alan Gonzalez, Leticia Stock, Mengrui Cao, Zeyu Qiao, Raymond E. Moellering, Savas Tay, Glenn Randall, Michael F. Beers, Marsha Rich Rosner, Scott A. Oakes, Susan R. Weiss

Summary: This study focused on the inositol-requiring enzyme 1 alpha (IRE1 alpha) pathway, which is part of the host unfolded protein response to virus-induced stress. The researchers found that while MERS-CoV and HCoV-OC43 fully activate the IRE1 alpha kinase and RNase activities, SARS-CoV-2 only partially activates IRE1 alpha, promoting its kinase activity but not RNase activity. Based on changes in IRE1 alpha-dependent gene expression during infection, the study suggests that SARS-CoV-2 inhibits the RNase activation of IRE1 alpha as a strategy to evade detection by the host immune system.
Article Chemistry, Medicinal

Transcriptional Inhibition of MicroRNA miR-122 by Small Molecules Reduces Hepatitis C Virus Replication in Liver Cells

Cole Emanuelson, Nicholas Ankenbruck, Rohan Kumbhare, Meryl Thomas, Colleen Connelly, Yasmine Baktash, Glenn Randall, Alexander Deiters

Summary: A new class of small-molecule miR-122 inhibitors has been discovered, which significantly reduces HCV replication in human liver cells, indicating their potential therapeutic importance.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Microbiology

CAPRIN1 Is Required for Control of Viral Replication Complexes by Interferon Gamma

Chaitanya Kurhade, Soowon Kang, Scott B. Biering, Seungmin Hwang, Glenn Randall

Summary: This study reveals the collaborative action of autophagy and interferon in inhibiting viral replication. It also uncovers the mechanism by which autophagy proteins target viral replication complexes and the role of interferon-inducible GTPases in disrupting these complexes. This research provides a new understanding of the recognition and inhibition of viral replication complexes by the autophagy machinery.
Article Biology

Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infection

Luise Hassler, Jan Wysocki, Jared T. Ahrendsen, Minghao Ye, Ian Gelarden, Vlad Nicolaescu, Anastasia Tomatsidou, Haley Gula, Cosimo Cianfarini, Peter Forster, Nigar Khurram, Benjamin D. Singer, Glenn Randall, Dominique Missiakas, Jack Henkin, Daniel Batlle

Summary: Soluble ACE2 protein (ACE2 618-DDC-ABD) administered intranasally improves survival and provides organ protection in SARS-CoV-2-inoculated mice.

LIFE SCIENCE ALLIANCE (2023)

暂无数据